India has retained the permanent ban, as reiterated by the Centre in March 2026 after an expert review, primarily due to concerns about "larger public interests" and the potential for even a "one percent chance of infection" being "injurious to the recipients," especially the vulnerable who rely on free blood facilities. While countries like the US, UK, and Canada have shifted to risk-based deferrals (e.g., deferring based on recent sexual activity), India's expert committee has maintained that diluting the ban would compromise blood safety. The implications include ongoing legal challenges (like Thangjam Santa Singh vs. Union of India) citing discrimination, and a continued debate on balancing public health mandates with fundamental rights and evolving scientific understanding of blood screening.

UPSC examiners might set a trap by presenting options that conflate "Men who have Sex with Men (MSM)" with a sexual identity or orientation. For instance, an MCQ might ask: "Which of the following statements about MSM is correct?" and include an option like "MSM refers exclusively to men who identify as gay or bisexual." The crucial point to remember is that MSM is a *behavioral classification* for public health purposes, not an *identity*. It includes any man who engages in sexual activity with other men, regardless of his self-identified sexual orientation (gay, bisexual, heterosexual, etc.). The term is deliberately identity-neutral to capture a broader population for epidemiological study.

Balancing these two is a complex challenge. From the government's perspective, the public health mandate (ensuring safe blood supply) is paramount, invoking the 'larger public interest' argument to justify the permanent deferral. They cite expert opinion and the potential risk, however small, to vulnerable recipients, aligning with the spirit of Article 21 (right to life) for the recipients. However, from the petitioners' viewpoint, a blanket ban on MSM violates fundamental rights like equality (Article 14), non-discrimination (Article 15), and the right to dignity and life (Article 21) for the donors. They argue that modern blood screening technologies can mitigate risks, and deferral should be based on individual risk assessment (recent risky behavior) rather than a group identity or past behavior. A balanced approach would involve exploring risk-based deferral policies, similar to those adopted by many developed nations, where eligibility is determined by recent sexual activity rather than a permanent exclusion based on identity or group classification. This would uphold public health safety while respecting individual rights and dignity.

The Centre's decision in March 2026 to retain the permanent ban, following a review by experts, was primarily driven by a cautious approach towards public health and recipient safety. The Additional Solicitor General stated that experts reiterated that diluting the ban would be "injurious to the recipients" and essential for "larger public interests." The Supreme Court, during initial hearings, also expressed reluctance to interfere, citing concerns about "even one percent chance of infection" for poor recipients who rely on free blood facilities. This indicates a strong emphasis on the precautionary principle, prioritizing the perceived safety of the general populace, particularly vulnerable blood recipients, over individual rights and the evolving scientific consensus on blood screening capabilities.

India has retained the permanent ban, as reiterated by the Centre in March 2026 after an expert review, primarily due to concerns about "larger public interests" and the potential for even a "one percent chance of infection" being "injurious to the recipients," especially the vulnerable who rely on free blood facilities. While countries like the US, UK, and Canada have shifted to risk-based deferrals (e.g., deferring based on recent sexual activity), India's expert committee has maintained that diluting the ban would compromise blood safety. The implications include ongoing legal challenges (like Thangjam Santa Singh vs. Union of India) citing discrimination, and a continued debate on balancing public health mandates with fundamental rights and evolving scientific understanding of blood screening.

UPSC examiners might set a trap by presenting options that conflate "Men who have Sex with Men (MSM)" with a sexual identity or orientation. For instance, an MCQ might ask: "Which of the following statements about MSM is correct?" and include an option like "MSM refers exclusively to men who identify as gay or bisexual." The crucial point to remember is that MSM is a *behavioral classification* for public health purposes, not an *identity*. It includes any man who engages in sexual activity with other men, regardless of his self-identified sexual orientation (gay, bisexual, heterosexual, etc.). The term is deliberately identity-neutral to capture a broader population for epidemiological study.

Balancing these two is a complex challenge. From the government's perspective, the public health mandate (ensuring safe blood supply) is paramount, invoking the 'larger public interest' argument to justify the permanent deferral. They cite expert opinion and the potential risk, however small, to vulnerable recipients, aligning with the spirit of Article 21 (right to life) for the recipients. However, from the petitioners' viewpoint, a blanket ban on MSM violates fundamental rights like equality (Article 14), non-discrimination (Article 15), and the right to dignity and life (Article 21) for the donors. They argue that modern blood screening technologies can mitigate risks, and deferral should be based on individual risk assessment (recent risky behavior) rather than a group identity or past behavior. A balanced approach would involve exploring risk-based deferral policies, similar to those adopted by many developed nations, where eligibility is determined by recent sexual activity rather than a permanent exclusion based on identity or group classification. This would uphold public health safety while respecting individual rights and dignity.

The Centre's decision in March 2026 to retain the permanent ban, following a review by experts, was primarily driven by a cautious approach towards public health and recipient safety. The Additional Solicitor General stated that experts reiterated that diluting the ban would be "injurious to the recipients" and essential for "larger public interests." The Supreme Court, during initial hearings, also expressed reluctance to interfere, citing concerns about "even one percent chance of infection" for poor recipients who rely on free blood facilities. This indicates a strong emphasis on the precautionary principle, prioritizing the perceived safety of the general populace, particularly vulnerable blood recipients, over individual rights and the evolving scientific consensus on blood screening capabilities.